文献速递胸部肿瘤乳腺癌消化系统肿瘤

癌症统计,2025年

Cancer statistics, 2025.
PubMed 文献 · CA Cancer J Clin · 2025-01-16

美国癌症协会基于截至2021年的发病率数据和截至2022年的死亡率数据,估算2025年美国将新发2,041,910例癌症和618,120例癌症死亡。

要点

  • 2025年美国预计新发癌症2,041,910例,癌症死亡618,120例。
  • 美洲原住民肾癌、肝癌、胃癌和宫颈癌死亡率是白人的2至3倍,黑人前列腺癌、胃癌和子宫体癌死亡率是白人的2倍。

核心结论

  • 癌症死亡率继续下降,但未来的进展受到种族不平等日益严重以及中年和年轻成人(尤其是女性)疾病负担加重的威胁。
  • 持续进步需要投资于癌症预防和公平获得治疗,尤其是对美洲原住民和黑人个体。

研究设计与样本

  • 美国癌症协会每年估算美国新发癌症病例和死亡人数,并汇编基于人群的癌症发病和结局最新数据。
  • 发病数据来自中央癌症登记处(截至2021年),死亡数据来自国家卫生统计中心(截至2022年)。

主要发现

  • 2025年美国预计发生2,041,910例新发癌症病例和618,120例癌症死亡。
  • 美洲原住民的癌症死亡率最高,其中肾癌、肝癌、胃癌和宫颈癌死亡率是白人的2至3倍。
  • 黑人前列腺癌、胃癌和子宫体癌死亡率是白人的2倍。
  • 男性总体癌症发病率普遍下降,但女性上升,男女发病率比从1992年峰值1.6(95%CI 1.57-1.61)缩小至2021年1.1(95%CI 1.12-1.12)。

关键数值与推荐

  • 50-64岁女性癌症发病率已超过男性(每10万人832.5例 vs 830.6例)。
  • 50岁以下女性癌症发病率比同龄男性高82%(每10万人141.1例 vs 77.4例),而2002年该差距为51%。
  • 2021年,65岁以下人群中女性肺癌发病率超过男性(每10万人15.7例 vs 15.4例;RR=0.98,p=0.03)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population-based cancer occurrence and outcomes using incidence data collected by central cancer registries (through 2021) and mortality data collected by the National Center for Health Statistics (through 2022). In 2025, 2,041,910 new cancer cases and 618,120 cancer deaths are projected to occur in the United States. The cancer mortality rate continued to decline through 2022, averting nearly 4.5 million deaths since 1991 because of smoking reductions, earlier detection for some cancers, and improved treatment. Yet alarming disparities persist; Native American people bear the highest cancer mortality, including rates that are two to three times those in White people for kidney, liver, stomach, and cervical cancers. Similarly, Black people have two-fold higher mortality than White people for prostate, stomach, and uterine corpus cancers. Overall cancer incidence has generally declined in men but has risen in women, narrowing the male-to-female rate ratio (RR) from a peak of 1.6 (95% confidence interval, 1.57-1.61) in 1992 to 1.1 (95% confidence interval, 1.12-1.12) in 2021. However, rates in women aged 50-64 years have already surpassed those in men (832.5 vs. 830.6 per 100,000), and younger women (younger than 50 years) have an 82% higher incidence rate than their male counterparts (141.1 vs. 77.4 per 100,000), up from 51% in 2002. Notably, lung cancer incidence in women surpassed that in men among people younger than 65 years in 2021 (15.7 vs. 15.4 per 100,000; RR, 0.98, p = 0.03). In summary, cancer mortality continues to decline, but future gains are threatened by rampant racial inequalities and a growing burden of disease in middle-aged and young adults, especially women. Continued progress will require investment in cancer prevention and access to equitable treatment, especially for Native American and Black individuals.

来源:CA Cancer J Clin,查看原文。版权归原作者所有。

引用

  1. Siegel RL, Kratzer TB, Giaquinto AN, et al. Cancer statistics, 2025. CA Cancer J Clin. 2025. PMID: 39817679. doi:10.3322/caac.21871

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。